{
    "clinical_study": {
        "@rank": "112756", 
        "acronym": "EPALI", 
        "arm_group": [
            {
                "arm_group_label": "Protective ventilation arm", 
                "arm_group_type": "Experimental", 
                "description": "Low tidal volumes (from 4 to 6 milliliters(mL)/kilogram (kg) of predicted body weight (PBW)\nPlateau pressure less than 25 centimeter of water (cmH2O)\nMinimum PEEP of 5 cmH2O."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "Active Comparator", 
                "description": "Traditional-sized tidal volumes (from 8 to 10 mL/kg PBW)\nPlateau pressure less than 25 cmH2O\nMinimum PEEP of 5 cmH2O."
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators hypothesis is that patients at risk of ARDS, detected by LIPS (Lung Injury\n      Prediction Score), under mechanical ventilation could benefit from a protective ventilatory\n      strategy (used in ARDS treatment) in order to avoid or decrease the ARDS development. This\n      would lead to a decrease in incidence, mortality and health care costs associated to this\n      syndrome.\n\n      This study will help to confirm the current evidence about low tidal volumes, evaluating\n      adverse events of this strategy."
        }, 
        "brief_title": "Preventive Strategies in Acute Respiratory Distress Syndrome (ARDS)", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "ARDS", 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Distress Syndrome, Newborn", 
                "Respiratory Distress Syndrome, Adult", 
                "Acute Lung Injury"
            ]
        }, 
        "detailed_description": {
            "textblock": "The main objective is to evaluate the effect of a protective ventilatory strategy by using\n      lower tidal volumes compared to the use of traditionally volumes in ARDS development."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients within 12 hours after start of invasive mechanical ventilation (MV) and\n             admitted to participating ICU (it is recommended an inclusion as soon as possible\n             during the first 3 hours).\n\n          -  LIPS > 4 points.\n\n          -  Absence of mild, moderate and severe ARDS criteria (Berlin definition).\n\n          -  Older than 18 year-old.\n\n          -  Signed informed consent\n\n        Exclusion Criteria:\n\n          -  Bilateral pulmonary infiltrates in chest X-ray at admission.\n\n          -  Mechanical ventilation > 12 hours.\n\n          -  Previous pneumonectomy or lobectomy.\n\n          -  Severe cranial trauma (Glasgow Coma Scale<9) or cranial hypertension.\n\n          -  Severe chronic pulmonary disease (GOLD IV).\n\n          -  Admission from other hospital under MV.\n\n          -  Limitation of therapeutic effort.\n\n          -  Pregnancy.\n\n          -  Acute pulmonary embolism.\n\n          -  Participation in other interventional trials.\n\n          -  Previous randomized in the proposed trial.\n\n          -  Absence of informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02070666", 
            "org_study_id": "EPALI"
        }, 
        "intervention": [
            {
                "arm_group_label": "Protective ventilation arm", 
                "description": "Ventilation mode: volume control, pressure control, dual modes (It is allowed to change to a spontaneous mode; a minimum of 5 cmH2O level of support should be used; in case the resulting tidal volume exceeds 6 mL/kg PBW this is accepted. This is not a reason to use more sedation and/or muscle relaxants, or to switch the ventilator to a controlled mode of ventilation).\nTidal volume: 6 mL/Kg PBW, decreasing 1 mL/kg PBW each step if necessary (steps of 5 minutes), to maintain plateau pressure < 25 cmH2O until a minimum tidal volume of 4 mL/Kg PBW, unless the patient suffers from severe dyspnea or unacceptable acidosis.\nFraction of inspired oxygen inspired oxygen fraction (FiO2) > 0.21 to maintain oxygen saturation 90-92%.\nPEEP \u2265 5 cmH2O, and optimized to maintain Oxygen saturation (SpO2) 90-92% (left to the discretion of the attending physician).\nPlateau pressure \u2264 25 cmH2O", 
                "intervention_name": "Protective mechanical ventilation", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Control group", 
                "description": "Ventilation mode: volume control, pressure control, dual modes (It is allowed to change to a spontaneous mode, with the level of support adjusted to reach tidal volumes minimum of 8 mL/kg predicted body weight PBW; if it is not possible, the data collection should be continue and an intention-to-treat analysis will be done).\nTidal volume: minimum 8 mL/kg PBW. It is possible to increase until 10 mL/kg PBW unless plateau pressure increases above 25 cmH2O.\n\u00b7 FiO2 > 0.21 to maintain oxygen saturation 90-92%.\nPEEP \u2265 5 cmH2O, and optimized to maintain SpO2 90-92% (left to the discretion of the attending physician).\nPlateau pressure \u2264 25 cm H2O.", 
                "intervention_name": "Control group", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Protective ventilation arm", 
                    "Control group"
                ], 
                "description": "Volumetric capnography will be used. Dead space (Vd/Vt) measurements will be taken at baseline and daily after initiation of mechanical ventilation. Nursing and respiratory care activities (including changes to ventilator settings) will be suspended for at least 5 minutes prior to all Vd/Vt measurements.", 
                "intervention_name": "Dead space", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "ARDS", 
            "Prevention", 
            "Protective mechanical ventilation", 
            "low tidal volumes"
        ], 
        "lastchanged_date": "February 21, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Sabadell", 
                    "country": "Spain", 
                    "state": "Barcelona", 
                    "zip": "08208"
                }, 
                "name": "Area de Cr\u00edticos, Hospital de Sabadell, Corporaci\u00f3n Sanitaria y Universitaria Parc Taul\u00ed"
            }, 
            "investigator": {
                "last_name": "Candelaria de Haro, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Preventive Strategies in Acute Respiratory Distress Syndrome", 
        "overall_contact": {
            "email": "cdeharo@tauli.cat", 
            "last_name": "Candelaria de Haro, MD", 
            "phone": "+34937231010", 
            "phone_ext": "21158"
        }, 
        "overall_contact_backup": {
            "email": "ggilis@tauli.cat", 
            "last_name": "Gisela Gili, RN", 
            "phone": "+3493721010", 
            "phone_ext": "21159"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To determine the effect of a protective mechanical ventilation strategy using lower tidal volumes as compared to mechanical ventilation using traditionally-sized tidal volumes on development of ARDS.", 
            "measure": "ARDS development", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02070666"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Corporacion Parc Tauli", 
            "investigator_full_name": "Antonio Artigas Ravent\u00f3s", 
            "investigator_title": "Director of Critical Care Arrea", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "In-hospital mortality, 28-day mortality and 90-day mortality", 
                "measure": "Mortality", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }, 
            {
                "description": "From 1 to 28 days over 28 days in a month", 
                "measure": "Ventilator-free days", 
                "safety_issue": "No", 
                "time_frame": "28 days after admission"
            }, 
            {
                "description": "Volumetric capnography", 
                "measure": "Dead space", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "description": "ICU stay and hospital stay", 
                "measure": "Length of stay", 
                "safety_issue": "No", 
                "time_frame": "participants will be followed for the duration of ICU (Intensive Care Unit) and hospital stay, an expected average of 4 weeks"
            }, 
            {
                "description": "Incidence of pneumonia", 
                "measure": "Pneumonia", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "description": "Incidence of atelectasis", 
                "measure": "Atelectasis", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }
        ], 
        "source": "Corporacion Parc Tauli", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Corporacion Parc Tauli", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}